XOMA Royalty Corp - 10-Q Filing
XOMA Royalty Corp filed a Form 10-Q for the quarter ended May 31, 2023. The filing includes details on royalty purchase agreements with companies like Dare and Viracta Therapeutics Inc., as well as contingent value rights related to Kinnate. It also outlines financial instruments such as preferred stock at-market agreements and loan arrangements.
Tickers: $XOMA